Original Research

Published on 13 Nov 2024

IGF2BP1 accelerates the aerobic glycolysis to boost its immune escape in hepatocellular carcinoma microenvironment

in Cancer Immunity and Immunotherapy

Xuxing Ye
Junmei Lin
Yanping Chen
Xiaobo Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480834

195 views

Review

Published on 13 Nov 2024

Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies

in Cancer Immunity and Immunotherapy

Olivier Nolan-Stevaux
Richard Smith

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490911

940 views

Original Research

Published on 13 Nov 2024

Advances in research on the relationship between mitochondrial function and colorectal cancer: a bibliometric study from 2013 to 2023

in Cancer Immunity and Immunotherapy

Jinhui Liu
Yonglong Chang
Qinling Ou
Linzi Chen
Haixia Yan
Duanyang Guo
Chongjie Wang
Sifang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480596

238 views

Original Research

Published on 13 Nov 2024

Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma

in Cancer Immunity and Immunotherapy

Jianmin Guo
Qiqi Wu
Hongjian Li
Chun Liang
Jinlong Dai
Shuren Zhang
Cailing Dai
Jishuai Zhang
Yuying Wen
Wei Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435934

235 views

Clinical Trial

Published on 13 Nov 2024

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial

in Cancer Immunity and Immunotherapy

Peng-Fei Zhang
Ye Chen
Wen-Ke Li
Zhu-Mei Luo
Ji Chen
Kun Qian
Xiao-Dong Chen
Mo-Jin Wang
Ming Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1431957

184 views

Review

Published on 13 Nov 2024

circFOXP1: a potential diagnostic and therapeutic target in human diseases

in Cancer Immunity and Immunotherapy

Qiang Yi
Xinting Ouyang
Kui Zhong
Zheng Chen
Weijian Zhu
Gangfeng Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489378

192 views

Review

Published on 13 Nov 2024

Nanomaterials: breaking the bottleneck of breast cancer drug resistance

in Cancer Immunity and Immunotherapy

Chao Guan
Yahao Han
Zhenzheng Ling
Xiang Meng
Baolin Zhang
Wanwei Dong
Di Zhang
Keyan Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492546

141 views

Review

Published on 13 Nov 2024

Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies

in Cancer Immunity and Immunotherapy

Yuanchun Ma
Ying Sun
Hongqian Guo
Rong Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418131

179 views

Correction

Published on 13 Nov 2024

Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

in Cancer Immunity and Immunotherapy

Wenqian Zhang
Jiewen Fu
Jiaman Du
Xiaoyan Liu
Jingliang Cheng
Chunli Wei
Youhua Xu
Junjiang Fu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1518823

104 views

Original Research

Published on 13 Nov 2024

Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora

in Cancer Immunity and Immunotherapy

Jiawen Wu
Sixue Lyu
Di Guo
Na Yang
Yang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488125

242 views

Original Research

Published on 13 Nov 2024

Comparison of treatment models for single primary advanced gallbladder cancer

in Cancer Immunity and Immunotherapy

Rongxuan Li
Xiao Chen
Bingchen Wang
Bolun Ai
Fangdi Min

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500091

192 views

Original Research

Published on 13 Nov 2024

A novel platelets-related gene signature for predicting prognosis, immune features and drug sensitivity in gastric cancer

in Cancer Immunity and Immunotherapy

Qun Li
Cheng Zhang
Yulin Ren
Lei Qiao
Shuning Xu
Ke Li
Ying Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477427

183 views

Systematic Review

Accepted on 12 Nov 2024

Antiangiogenic Therapy Exerts Antitumor Effects by Altering the Tumor Microenvironment: Bibliometric Analysis

in Cancer Immunity and Immunotherapy

Kang Yuan
zhang dian bao
kang yi xin
yao jun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460533

Original Research

Accepted on 12 Nov 2024

Prognostic Model Based on Disulfidptosis-Related lncRNAs for Predicting Survival and Therapeutic Response in Bladder Cancer

in Cancer Immunity and Immunotherapy

LIrui Han
Hankai Yang
Xuan Jiang
Ziyu Zhou
Chang Ge
Kairan Yu
Guofang Li
Yubo Liu
Wei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512203

Original Research

Accepted on 12 Nov 2024

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

in Cancer Immunity and Immunotherapy

Yingtao Lin
Cijuan Li
Chang Wang
Jian Chen
Yuanqing Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481584

101 views

Original Research

Accepted on 12 Nov 2024

Single-Cell RNA-Seq Reveals FGF12 as a Prognostic Biomarker in Low-Grade Endometrial Stromal Sarcoma

in Cancer Immunity and Immunotherapy

Yu Miao
Meng Dong
Qiyin Zhou
Julia Thiel
Na Li
Ying Cai
Dan Yuan
Haitao Wang
Su-Han Jin
Hua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513076

Navigation group

Articles

IGF2BP1 accelerates the aerobic glycolysis to boost its immune escape in hepatocellular carcinoma microenvironment

Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies

Advances in research on the relationship between mitochondrial function and colorectal cancer: a bibliometric study from 2013 to 2023

Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma

SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial

circFOXP1: a potential diagnostic and therapeutic target in human diseases

Nanomaterials: breaking the bottleneck of breast cancer drug resistance

Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies

Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora

Comparison of treatment models for single primary advanced gallbladder cancer

A novel platelets-related gene signature for predicting prognosis, immune features and drug sensitivity in gastric cancer

Antiangiogenic Therapy Exerts Antitumor Effects by Altering the Tumor Microenvironment: Bibliometric Analysis

Prognostic Model Based on Disulfidptosis-Related lncRNAs for Predicting Survival and Therapeutic Response in Bladder Cancer

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

Single-Cell RNA-Seq Reveals FGF12 as a Prognostic Biomarker in Low-Grade Endometrial Stromal Sarcoma